Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
71%(5 trials)

Phase Distribution

Ph not_applicable
2
20%
Ph phase_4
3
30%
Ph phase_3
5
50%

Phase Distribution

0

Early Stage

0

Mid Stage

8

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
5(50.0%)
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 35 (50.0%)
Phase 43 (30.0%)
N/A2 (20.0%)

Trials by Status

unknown220%
withdrawn110%
completed770%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10